Summary

Respiratory care in Europe is a vital component of healthcare, with a focus on addressing respiratory diseases and improving overall lung health. This region places a strong emphasis on research, prevention, and treatment of conditions. Europe is home to a highly qualified medical staff, a variety of treatment alternatives, and state-of-the-art diagnostic and diagnostic technologies. Furthermore, the European Respiratory Society (ERS) is essential to the advancement of respiratory care advocacy, teaching, and research. Europe is making tremendous progress in raising the standard of care and improving the lives of those who are impacted by respiratory problems as a result of a rising understanding of the significance of lung health and the necessity of efficient management of respiratory disorders. One of the primary reasons for Europe's success in this sector is its strong focus on research and development. Leading companies invest heavily in R&D, which enables them to innovate and introduce advanced technologies that improve patient outcomes continuously. This commitment to innovation also extends to environmentally sustainable practices, with an emphasis on energy efficiency and reducing the environmental footprint of respiratory care devices. Additionally, Europe boasts a highly skilled and well-educated workforce in the field of medical technology. Along with this, The UK has one of the highest prevalence, emergency admission and death rates for childhood asthma in Europe. One million children in the UK are receiving treatment for asthma. As the burden of respiratory diseases grows, so does the demand for respiratory care devices. The need for advanced treatments and management solutions, such as inhalers, nebulizers, oxygen concentrators, and ventilators, is on the rise. Also, According to the National Liberary of Meficine (NIH) report, the current prevalence of chronic obstructive pulmonary disease (COPD) in France is estimated to be 2.6 million and is predicted to increase to 2.8 million by 2025. As the burden of these conditions continues to rise in Europe, the need for advanced respiratory care devices is becoming increasingly paramount. These devices, which encompass a wide range of technologies, from inhalers and nebulizers to oxygen concentrators and ventilators, play a pivotal role in managing and alleviating the symptoms associated with respiratory disorders, thereby enhancing the quality of life for affected individuals. The escalating demand for these devices is not only a response to the growing prevalence of respiratory disorders but also a reflection of the evolving healthcare landscape, where emphasis is being placed on the early diagnosis, effective management, and on-going care of these conditions. Furthermore, these devices are pivotal in reducing the burden on healthcare facilities and personnel, as they empower individuals to take charge of their respiratory health from the comfort of their own homes.

According to the research report, “Europe Respiratory Care Devices Market Outlook, 2028” published by Bonafide Research, the market is projected to add more than USD 2.5 Billion from 2023-2028. The market for respiratory care equipment is developing significantly in Europe, due to the increasing significance of respiratory health and the on-going progress in medical technology. The prevalence of these respiratory illnesses is rising along with Europe's aging population, which means there will always be a need for creative ways to manage and treat these problems. The COVID-19 pandemic has brought to light the vital role that respiratory care equipment—ventilators and oxygen therapy supplies, in particular—plays in helping patients who are experiencing severe respiratory distress. Due to increased understanding of the value of these devices in emergency scenarios, healthcare infrastructure and stockpiles have been invested in to assure readiness for unforeseen circumstances. Europe's reputation for quality and precision in manufacturing has positioned it as a preferred destination for both domestic and international consumers seeking reliable and high-performance respiratory care devices. Europe manufacturers have continued to invest in research and development, resulting in the introduction of state-of-the-art devices with enhanced features, greater patient comfort, and improved therapeutic outcomes. The Europe countries government's commitment to healthcare and the presence of a robust regulatory framework ensure that respiratory care devices are produced in compliance with the highest safety and quality standards. This regulatory certainty and adherence to international standards have further bolstered the country's position as a trusted supplier in the global market.

Europe's respiratory care devices market is segmented into several countries, each of which adds to the region's overall healthcare environment. The United Kingdom is a noteworthy leader in this sector, showcasing a strong dedication to respiratory treatment and wellness. The United Kingdom boasts a highly developed healthcare infrastructure that prioritizes cutting-edge treatment choices, research, and illness management. Because of this, the UK is a leader in the European respiratory care sector and has made great advancements in the identification, management, and avoidance of respiratory diseases. Following closely behind, Germany also plays a pivotal role in this sector. Germany is well-known for emphasizing innovation and healthcare technology, and it has made a significant contribution to the respiratory care equipment market. Modern respiratory treatments and technologies have been developed as a result of the nation's research and development initiatives as well as its strong healthcare system. Nonetheless, Russia, France, Spain, and Italy are also very important in promoting respiratory care in Europe. Each of these nations has particular advantages and top priorities in healthcare. For example, France is well known for its proficiency in medical research, having played a significant role in the creation of novel therapeutic approaches and diagnostic instruments. Spain is concentrating on improving the accessibility and affordability of respiratory care as a result of its growing healthcare infrastructure. Conversely, Italy is renowned for its dedication to wellness and public health, placing a strong emphasis on respiratory health. Russia, one of the biggest nations in the area, deals with the particular difficulties in offering respiratory care to its enormous and varied populace.

The market for respiratory care products is divided into a number of product types-based categories, such as diagnostic, therapeutic, and monitoring devices, as well as consumables and accessories. Therapeutic devices are the most popular and have a large market share among these categories. When it comes to treating and enhancing the respiratory health of people with problems like asthma, COPD, sleep apnea, and other respiratory disorders, these therapeutic devices are essential. Therapeutic devices encompass a wide range of equipment and technologies, including inhalers, nebulizers, ventilators, continuous positive airway pressure (CPAP) machines, and oxygen therapy devices. These devices are essential for delivering medication, managing airflow, and providing respiratory support, making them fundamental to the treatment and care of patients with respiratory conditions. The dominance of therapeutic devices in the market is often attributed to the increasing prevalence of respiratory diseases, the growing aging population, and the need for effective and accessible treatment options. Notably, the market landscape is not solely defined by therapeutic devices; monitoring and diagnostic devices also wield substantial influence, collectively commanding a significant share. Monitoring devices, such as pulse oximeters and spirometers, are essential tools for tracking the vital parameters of patients with respiratory issues. They enable early intervention and improved illness management by giving patients and healthcare providers access to vital real-time data. Diagnostic tools, such as pulmonary function tests and advanced imaging technologies, enable prompt and accurate diagnosis, which is essential for guaranteeing the right course of therapy. The category of consumables and accessories, which includes products like masks, filters, and tubing required for the operation of respiratory equipment, adds to the market's diversity and dynamism.

In the European landscape of respiratory equipment market segmentation based on disease indication, Chronic Obstructive Pulmonary Disease (COPD) stands as the leading and substantial market driver. COPD, a chronic inflammatory lung condition often caused by long-term exposure to irritants, significantly influences the demand for respiratory devices, marking a considerable portion of the market. The necessity for a wide range of therapeutic solutions such as inhalers, nebulizers, and oxygen therapy devices to manage COPD symptoms solidifies its dominant position in the market. This prevalence is notably attributed to the high incidence rates across Europe due to environmental factors, including smoking and air pollution. Following COPD, sleep apnea occupies a noteworthy segment in the market. Sleep apnea, characterized by intermittent breathing pauses during sleep, necessitates specialized respiratory devices like Continuous Positive Airway Pressure (CPAP) machines. The increased awareness and diagnosis of sleep disorders have contributed to the growing market share of sleep apnea-related equipment. Additionally, asthma maintains a significant market presence in Europe. This chronic respiratory condition, characterized by airway inflammation and constriction, drives the demand for inhalers, spacers, and nebulizers, essential in managing asthma symptoms. The collective impact of COPD, sleep apnea, and asthma underscores the importance of a wide array of respiratory devices tailored to these prevalent conditions, demonstrating the market's adaptability and responsiveness to the diverse respiratory health challenges across the region. Shifting focus, infectious diseases constitute a significant section of the European respiratory equipment market, notably amplified by recent global health concerns.

Within the European market for respiratory equipment, the segmentation based on end users delineates hospitals as the central cornerstone, serving as major players in this sector. Hospitals stand as essential hubs for respiratory care due to their extensive infrastructure, specialized medical expertise, and immediate access to a comprehensive array of respiratory devices. These institutions play a pivotal role in catering to a broad spectrum of respiratory needs, managing acute, critical, and severe cases, and offering a wide range of respiratory equipment, including ventilators, oxygen concentrators, and specialized monitoring tools. Their role in providing immediate and intensive care is pivotal in addressing respiratory ailments effectively. However, as the landscape of healthcare continues to evolve, an evident shift is underway, gradually elevating the significance of home care settings in the market. The emerging trend points to the increasing prominence of home care solutions, with an emphasis on patient-centred care, technological advancements enabling user-friendly and portable respiratory devices, and a growing preference for healthcare services within the comfort of one's residence. With a rising incidence of chronic respiratory conditions like COPD and sleep apnea, there's a noticeable surge in demand for effective home care solutions. This trend anticipates that home care settings will secure a more substantial market share in the future, offering patients practical respiratory equipment for use at home. The evolving prominence of home care settings not only aims to enhance patient comfort but also strives to reduce healthcare costs and provide more personalized care options, marking a notable shift in the landscape of respiratory care within the European market.

Companies Covered in this report:
Koninklijke Philips N.V., Medtronic Inc, Masimo Corporation, Cardinal Health, Inc, Medline Industries, Baxter International Inc., Stryker Corporation, Siemens AG , GE HealthCare, Technologies, Inc., Teleflex Incorporated, ResMed Inc.

Considered in this report:
• Geography: Europe
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Europe Respiratory Care Devices market Outlook with its value and forecast along with its segments
• Country-wise Respiratory Care Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.



***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents